Robert L. Talbert

4.3k total citations
117 papers, 2.7k citations indexed

About

Robert L. Talbert is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Geriatrics and Gerontology. According to data from OpenAlex, Robert L. Talbert has authored 117 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 18 papers in Geriatrics and Gerontology. Recurrent topics in Robert L. Talbert's work include Pharmaceutical Practices and Patient Outcomes (18 papers), Pharmaceutical studies and practices (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (15 papers). Robert L. Talbert is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (18 papers), Pharmaceutical studies and practices (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (15 papers). Robert L. Talbert collaborates with scholars based in United States, Canada and Spain. Robert L. Talbert's co-authors include Kent Nelson, David S. Burgess, Jay I. Peters, Robert G. Hart, Mark J. Cziraky, Lesly A. Pearce, Peter J. Smith, Karol E. Watson, Robert O. Williams and Shireen Banerji and has published in prestigious journals such as Annals of Internal Medicine, Neurology and Stroke.

In The Last Decade

Robert L. Talbert

113 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Talbert United States 31 715 494 407 390 326 117 2.7k
Sebastian Harder Germany 34 1.0k 1.4× 385 0.8× 549 1.3× 214 0.5× 402 1.2× 109 3.5k
George R. Aronoff United States 32 421 0.6× 293 0.6× 265 0.7× 391 1.0× 301 0.9× 126 3.6k
Emanuel Raschi Italy 34 851 1.2× 342 0.7× 436 1.1× 421 1.1× 636 2.0× 169 4.1k
Dylan W. de Lange Netherlands 35 396 0.6× 1.0k 2.0× 423 1.0× 519 1.3× 239 0.7× 203 3.9k
Francisco J. de Abajo Spain 34 705 1.0× 848 1.7× 491 1.2× 248 0.6× 219 0.7× 130 3.8k
Timothy H. Self United States 26 367 0.5× 433 0.9× 276 0.7× 907 2.3× 201 0.6× 158 3.0k
Ronen Loebstein Israel 31 422 0.6× 530 1.1× 406 1.0× 146 0.4× 230 0.7× 75 3.0k
Allan J. McLean Australia 29 344 0.5× 755 1.5× 351 0.9× 178 0.5× 390 1.2× 77 3.2k
Mordechai Muszkat Israel 25 664 0.9× 239 0.5× 211 0.5× 179 0.5× 332 1.0× 105 2.4k
Thomas D. Nolin United States 39 640 0.9× 310 0.6× 383 0.9× 405 1.0× 819 2.5× 135 4.3k

Countries citing papers authored by Robert L. Talbert

Since Specialization
Citations

This map shows the geographic impact of Robert L. Talbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Talbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Talbert more than expected).

Fields of papers citing papers by Robert L. Talbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Talbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Talbert. The network helps show where Robert L. Talbert may publish in the future.

Co-authorship network of co-authors of Robert L. Talbert

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Talbert. A scholar is included among the top collaborators of Robert L. Talbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Talbert. Robert L. Talbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rouby, Nihal El, Caitrin W. McDonough, Yan Gong, et al.. (2018). Genome-wide association analysis of common genetic variants of resistant hypertension. The Pharmacogenomics Journal. 19(3). 295–304. 16 indexed citations
2.
White, Carole L., Pablo E. Pérgola, Jeff M. Szychowski, et al.. (2013). Blood Pressure After Recent Stroke: Baseline Findings From the Secondary Prevention of Small Subcortical Strokes Trial. American Journal of Hypertension. 26(9). 1114–1122. 28 indexed citations
3.
Talbert, Robert L., et al.. (2010). Proton pump inhibitors and clopidogrel: is it a significant drug interaction?. Expert Opinion on Drug Safety. 9(4). 593–602. 12 indexed citations
4.
Talbert, Robert L., et al.. (2007). Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin. Antimicrobial Agents and Chemotherapy. 52(3). 1144–1146. 61 indexed citations
5.
Ito, Matthew K., Robert L. Talbert, & Sotirios Tsimikas. (2006). Statin‐Associated Pleiotropy: Possible Beneficial Effects Beyond Cholesterol Reduction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(7P2). 85S–97S; discussion 98S. 43 indexed citations
6.
McConville, Jason T., David S. Burgess, Jay I. Peters, et al.. (2006). Single dose and multiple dose studies of itraconazole nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 63(2). 95–102. 67 indexed citations
7.
McConville, Jason T., Thiago C. Carvalho, Robert L. Talbert, et al.. (2005). Design and Evaluation of a Restraint-Free Small Animal Inhalation Dosing Chamber. Drug Development and Industrial Pharmacy. 31(1). 35–42. 13 indexed citations
8.
Frei, Christopher R., Jim M. Koeller, David S. Burgess, Robert L. Talbert, & Michael Johnsrud. (2003). Impact of Atypical Coverage for Patients with Community‐Acquired Pneumonia Managed on the Medical Ward: Results from the United States Community‐Acquired Pneumonia Project. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(9). 1167–1174. 22 indexed citations
9.
Talbert, Robert L., Sarah A. Spinler, Jean M. Nappi, & Michael B. Bottorff. (2002). Combination Antiplatelet Therapy: Implications for Pharmacists. Journal of the American Pharmaceutical Association (1996). 42(6). 880–883. 1 indexed citations
10.
Talbert, Robert L.. (1997). ACCP Strategic Planning Conference: Issues and Trends in Clinical Pharmacy Education. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(5). 1073–1078. 1 indexed citations
11.
Nelson, Kent & Robert L. Talbert. (1996). Drug‐Related Hospital Admissions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 701–707. 131 indexed citations
12.
Hart, Robert G., et al.. (1996). Warfarin for prevention of stroke: A practical, clinical review. The Neurologist. 2(6). 319–341. 1 indexed citations
13.
Talbert, Robert L.. (1996). Strategies in the Management of Acute Myocardial Infarction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(5P2). 127S–136S. 1 indexed citations
14.
Talbert, Robert L., et al.. (1994). Management of Thyroid Disorders. American Pharmacy. 34(12). 36–47. 4 indexed citations
15.
Talbert, Robert L.. (1993). Ethics in Clinical Pharmacy Practice and Research: An Introduction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(5). 521–522. 2 indexed citations
16.
Zarowitz, Barbara J., Peter H. Vlasses, George E. Dukes, et al.. (1993). Pharmacotherapy Specialty Certification Examination. IV. 1992 Results and Process Modifications, Including Recertification. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(3). 262–266. 3 indexed citations
17.
Miller, William A., George E. Dukes, Péter Gál, et al.. (1992). Recognition of Pharmacotherapy as a Pharmacy Practice Specialty: An Historical Account and View of the Future. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(6). 475–476. 2 indexed citations
18.
Mueller, Bruce A., Robert L. Talbert, Charles H. Tegeler, & Thomas J. Prihoda. (1991). The Bleeding Time Effects of a Single Dose of Aspirin in Subjects Receiving Omega‐3 Fatty Acid Dietary Supplementation. The Journal of Clinical Pharmacology. 31(2). 185–190. 15 indexed citations
19.
Prihoda, Thomas J., et al.. (1989). An Objective Method of Compliance Assessment with Metered-Dose Inhalers. DICP. 23(2). 128–132. 2 indexed citations
20.
Talbert, Robert L., et al.. (1980). Development of a loading regimen for aspirin. Current Therapeutic Research. 27(4). 589–594. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Harder Breakdown of academic impact, for papers by George R. Aronoff Breakdown of academic impact, for papers by Emanuel Raschi Breakdown of academic impact, for papers by Dylan W. de Lange Breakdown of academic impact, for papers by Francisco J. de Abajo Breakdown of academic impact, for papers by Timothy H. Self Breakdown of academic impact, for papers by Ronen Loebstein Breakdown of academic impact, for papers by Allan J. McLean Breakdown of academic impact, for papers by Mordechai Muszkat Breakdown of academic impact, for papers by Thomas D. Nolin
Rankless by CCL
2026